246 related articles for article (PubMed ID: 19743577)
1. Adverse effects of papillomavirus vaccines: pharmacovigilance data in 2008.
Prescrire Int; 2009 Aug; 18(102):163. PubMed ID: 19743577
[TBL] [Abstract][Full Text] [Related]
2. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus vaccines.
Satyaprakash A; Creed R; Ravanfar P; Mendoza N
Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
[TBL] [Abstract][Full Text] [Related]
4. Vaccinating adolescents and young women against cancer of the cervix.
Hilgers RD; Wyatt SW
J Ky Med Assoc; 2007 May; 105(5):215-6. PubMed ID: 17566465
[No Abstract] [Full Text] [Related]
5. Herd immunity.
O'Connor K
Aust Fam Physician; 2007 Sep; 36(9):677. PubMed ID: 17915372
[No Abstract] [Full Text] [Related]
6. One in four California adolescent girls have had human papillomavirus vaccination.
Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
[No Abstract] [Full Text] [Related]
7. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
Harper DM
Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance.
Gold MS; McIntyre P
Sex Health; 2010 Sep; 7(3):320-4. PubMed ID: 20719221
[TBL] [Abstract][Full Text] [Related]
9. [In defence of women against HPV-infection].
Blázovics A
Orv Hetil; 2007 Apr; 148(17):813. PubMed ID: 17452313
[No Abstract] [Full Text] [Related]
10. Towards global prevention of human papillomavirus-induced cancer.
Roden RB; Gravitt P; Wu TC
Eur J Immunol; 2008 Feb; 38(2):323-6. PubMed ID: 18228245
[No Abstract] [Full Text] [Related]
11. Human papillomavirus vaccination: expected impacts and unresolved issues.
Dempsey AF; Freed GL
J Pediatr; 2008 Mar; 152(3):305-9. PubMed ID: 18280831
[No Abstract] [Full Text] [Related]
12. [Safety of the bivalent human papillomavirus vaccine--results following administration of more than 192,000 doses].
van der Maas NA; Kemmeren JM; de Melker HE
Ned Tijdschr Geneeskd; 2009; 153():A964. PubMed ID: 19930738
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus vaccines: what does the future hold for preventing cervical cancer in resource-poor settings through immunization programs?
Jacob M; Bradley J; Barone MA
Sex Transm Dis; 2005 Oct; 32(10):635-40. PubMed ID: 16205306
[No Abstract] [Full Text] [Related]
14. Primary and secondary prevention of cervical cancer--opportunities and challenges.
Markowitz LE; Unger ER; Saraiya M
J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638
[No Abstract] [Full Text] [Related]
15. HPV vaccination.
Brotherton J
Aust Fam Physician; 2007 Jun; 36(6):391; author reply 391. PubMed ID: 17582901
[No Abstract] [Full Text] [Related]
16. Trends in Genital Warts in the Era of Human Papillomavirus Vaccination.
Calo WA; Brewer NT
Sex Transm Dis; 2015 Dec; 42(12):669-70. PubMed ID: 26560967
[No Abstract] [Full Text] [Related]
17. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types.
Herrero R
J Infect Dis; 2009 Apr; 199(7):919-22. PubMed ID: 19236278
[No Abstract] [Full Text] [Related]
18. Gardasil needs a new consent form.
Harper DM
Expert Rev Vaccines; 2009 Dec; 8(12):1613-4. PubMed ID: 19943754
[No Abstract] [Full Text] [Related]
19. HPV related surveillance activities in Australia.
Brotherton J; Kaldor JM; McIntyre P
Vaccine; 2010 Nov; 28(47):7453-4. PubMed ID: 20854898
[No Abstract] [Full Text] [Related]
20. Doubts on the appropriateness of universal human papillomavirus vaccination: is evidence on public health benefits already available?
Porta M; González B; Márquez S; Artazcoz L
J Epidemiol Community Health; 2008 Aug; 62(8):667. PubMed ID: 18621949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
